The value of serum laminin P1 in monitoring disease activity in patients with systemic lupus erythematosus.
Schneider
M
M
Department B, University of Münster, FRG.
Hengst
K
K
Waldendorf
M
M
Högemann
B
B
Gerlach
U
U
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007797:Laminin / Q000097:blood*; D008180:Lupus Erythematosus, Systemic / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology; D008181:Lupus Nephritis / Q000097:blood / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods; D009994:Osmolar Concentration; D010446:Peptide Fragments / Q000097:blood*
D007166:Immunosuppressive Agents; D007797:Laminin; D010446:Peptide Fragments; C055716:laminin P1